Suchergebnisse - "Kakavand, Hessam"

PubPharm (16)

1

Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials

enthalten in: bioRxiv.org | 2023

von Talasaz, A. | Sadeghipour, P. | Aghakouchakzadeh, M. | +20

2

Atorvastatin versus Placebo in ICU Patients with COVID-19 : Ninety-day Results of the INSPIRATION-S Trial

enthalten in: Thrombosis and haemostasis | 2023

von Talasaz, A. | Sadeghipour, P. | Bakhshandeh, H. | +64

3

Atorvastatin versus placebo in patients with covid-19 in intensive care : randomized controlled trial

enthalten in: BMJ (Clinical research ed.) | 2022

von INSPIRATION-S Investigators | Bikdeli, B. | Talasaz, A. | +64

4

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit : 90-Day Results from the INSPIRATION Randomized Trial

enthalten in: Thrombosis and haemostasis | 2022

von Bikdeli, B. | Talasaz, A. | Rashidi, F. | +57

5

Use of novel antithrombotic agents for COVID-19 : Systematic summary of ongoing randomized controlled trials

enthalten in: Journal of thrombosis and haemostasis : JTH | 2021

von Talasaz, A. | Sadeghipour, P. | Aghakouchakzadeh, M. | +13

6

Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19 : JACC State-of-the-Art Review

enthalten in: Journal of the American College of Cardiology | 2021

von Talasaz, A. | Sadeghipour, P. | Aghakouchakzadeh, M. | +20

UpdateOf: medRxiv. 2021 May 04;:. - PMID 33972948

7

Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials

enthalten in: bioRxiv.org | 2021

von Talasaz, A. | Sadeghipour, P. | Kakavand, H. | +24

8

Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials

enthalten in: medRxiv : the preprint server for health sciences | 2021

von Talasaz, A. | Sadeghipour, P. | Aghakouchakzadeh, M. | +20

UpdateIn: J Am Coll Cardiol. 2021 Oct 19;78(16):1635-1654. - PMID 34649702

9

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit : The INSPIRATION Randomized Clinical Trial

enthalten in: JAMA | 2021

von INSPIRATION Investigators | Sadeghipour, P. | Talasaz, A. | +77

CommentIn: JAMA. 2021 Apr 27;325(16):1613-1615. - PMID 33734290

10

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19 : JACC State-of-the-Art Review

enthalten in: Journal of the American College of Cardiology | 2021

von Talasaz, A. | Sadeghipour, P. | Kakavand, H. | +24